Literature DB >> 9085535

Changes in airway characteristics after transpalatal advancement pharyngoplasty compared to uvulopalatopharyngoplasty (UPPP).

B T Woodson1.   

Abstract

Transpalatal advancement pharyngoplasty is postulated to enlarge the retropalatal airway compared to uvulopalatopharyngoplasty (UPPP) for treatment of the obstructive sleep apnea syndrome (OSAS). Surgical success in treating OSAS has been associated with increasing size and decreasing collapsibility of the retropalatal airway to prevent airway obstruction. To compare transpalatal advancement pharyngoplasty compared to UPPP, upper airway characteristics were measured following each procedure in seven patients using a quantitative endoscopic technique. Following transpalatal advancement pharyngoplasty, maximal retropalatal airway size increased 220% from 61.5 to 135.0 mm2 (p < 0.001), and retropalatal closing pressure decreased 9.2 cm H2O from 5 to -4.2 cm/H2O (p < 0.001) compared to UPPP. Results demonstrate that transpalatal advancement pharyngoplasty significantly increases retropalatal size and decrease retropalatal collapsibility compared to UPPP. Since these characteristics contribute to increased stability, transpalatal advancement pharyngoplasty may improve traditional UPPP. Studies of airway mechanics may assist in improving surgical treatment of OSAS.

Entities:  

Mesh:

Year:  1996        PMID: 9085535     DOI: 10.1093/sleep/19.suppl_10.s291

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  2 in total

1.  Upper airway collapsibility in patients with OSA treated with continuous positive airway pressure: a retrospective preliminary study.

Authors:  Marcello Bosi; Serena Incerti Parenti; Andrea Fiordelli; Venerino Poletti; Giulio Alessandri-Bonetti
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

Review 2.  Transpalatal advancement pharyngoplasty for obstructive sleep apnea: a systematic review and meta-analysis.

Authors:  Keith Volner; Brandyn Dunn; Edward T Chang; Sungjin A Song; Stanley Yung-Chuan Liu; Scott E Brietzke; Peter O'Connor; Macario Camacho
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-11       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.